Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2

Journal Article · · Glycobiology (Online)
 [1];  [2];  [2];  [2];  [2];  [2]
  1. Complex Carbohydrate Research Center, The University of Georgia, 315 Riverbend Rd, Athens, GA 30602, USA; OSTI
  2. Complex Carbohydrate Research Center, The University of Georgia, 315 Riverbend Rd, Athens, GA 30602, USA

Abstract

The emergence of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created the need for development of new therapeutic strategies. Understanding the mode of viral attachment, entry and replication has become a key aspect of such interventions. The coronavirus surface features a trimeric spike (S) protein that is essential for viral attachment, entry and membrane fusion. The S protein of SARS-CoV-2 binds to human angiotensin converting enzyme 2 (hACE2) for entry. Herein, we describe glycomic and glycoproteomic analysis of hACE2 expressed in HEK293 cells. We observed high glycan occupancy (73.2 to 100%) at all seven possible N-glycosylation sites and surprisingly detected one novel O-glycosylation site. To deduce the detailed structure of glycan epitopes on hACE2 that may be involved in viral binding, we have characterized the terminal sialic acid linkages, the presence of bisecting GlcNAc and the pattern of N-glycan fucosylation. We have conducted extensive manual interpretation of each glycopeptide and glycan spectrum, in addition to using bioinformatics tools to validate the hACE2 glycosylation. Our elucidation of the site-specific glycosylation and its terminal orientations on the hACE2 receptor, along with the modeling of hACE2 glycosylation sites can aid in understanding the intriguing virus-receptor interactions and assist in the development of novel therapeutics to prevent viral entry. The relevance of studying the role of ACE2 is further increased due to some recent reports about the varying ACE2 dependent complications with regard to age, sex, race and pre-existing conditions of COVID-19 patients.

Research Organization:
Univ. of Georgia, Athens, GA (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
DOE Contract Number:
SC0015662
OSTI ID:
1852017
Journal Information:
Glycobiology (Online), Journal Name: Glycobiology (Online) Journal Issue: 4 Vol. 31; ISSN 1460-2423
Publisher:
Oxford University Press
Country of Publication:
United States
Language:
English

References (61)

Therapeutic options for the 2019 novel coronavirus (2019-nCoV) journal February 2020
Glycosylation of Therapeutic Proteins: An Effective Strategy to Optimize Efficacy journal January 2010
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses journal February 2020
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets journal April 2014
Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin journal January 2008
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein journal April 2020
Glycoproteomics Analysis of Human Liver Tissue by Combination of Multiple Enzyme Digestion and Hydrazide Chemistry journal February 2009
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc journal April 2008
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 journal May 2020
Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2 journal August 2018
Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 journal May 2020
Database Analysis of O-Glycosylation Sites in Proteins journal February 2001
Expression of 9- O - and 7,9- O -Acetyl Modified Sialic Acid in Cells and Their Effects on Influenza Viruses journal December 2019
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus journal January 2020
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 journal March 2020
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2 journal August 2020
Determination of true ratios of different N-glycan structures in electrospray ionization mass spectrometry journal March 2017
Tool for Rapid Analysis of Glycopeptide by Permethylation via One-Pot Site Mapping and Glycan Analysis journal October 2017
Angiotensin-Converting Enzyme 2 Ectodomain Shedding Cleavage-Site Identification: Determinants and Constraints journal May 2011
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation journal February 2020
Site-specific glycan analysis of the SARS-CoV-2 spike journal May 2020
Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry journal June 2010
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury journal July 2005
Structural basis for human coronavirus attachment to sialic acid receptors journal June 2019
Glycomic and glycoproteomic analysis of glycoproteins—a tutorial journal June 2017
Structural basis of receptor recognition by SARS-CoV-2 journal March 2020
The proximal origin of SARS-CoV-2 journal March 2020
A Human Homolog of Angiotensin-converting Enzyme journal October 2000
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein journal September 2017
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB journal April 2020
A Proteomic Analysis of Human Bile journal July 2004
GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins journal December 2009
Database Analysis of O-Glycosylation Sites in Proteins journal February 2001
Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor journal July 2004
Unravelling the Role of O-glycans in Influenza A Virus Infection journal November 2018
Concepts and Principles of O-Linked Glycosylation journal January 1998
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry journal May 2005
GlyGen: Computational and Informatics Resources for Glycoscience journal October 2019
Receptor recognition and cross-species infections of SARS coronavirus journal October 2013
Intact glycopeptide characterization using mass spectrometry journal April 2016
Mass spectrometric glycan rearrangements journal May 2011
Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry journal June 2008
Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors journal December 2019
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein journal September 2020
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor journal October 2020
ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis journal January 2004
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2 journal July 2020
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2 journal May 2020
A pneumonia outbreak associated with a new coronavirus of probable bat origin journal February 2020
The structures of glycophorin C N-glycans, a putative component of the GPC receptor site for Plasmodium falciparum EBA-140 ligand journal December 2014
Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression journal March 2015
ADAM17 inhibition may exert a protective effect on COVID-19 journal April 2020
Expression of 9- O - and 7,9- O -Acetyl Modified Sialic Acid in Cells and Their Effects on Influenza Viruses journal December 2019
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 journal September 2000
COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children journal April 2020
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor journal April 2020
Simplifying Glycan Profiling through a High-Throughput Micropermethylation Strategy journal May 2020
Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia journal July 2009
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus journal November 2003
Inhibition of Endoplasmic Reticulum-Resident Glucosidases Impairs Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Spike Protein-Mediated Entry by Altering the Glycan Processing of Angiotensin I-Converting Enzyme 2 journal October 2014
Highly Conserved Regions within the Spike Proteins of Human Coronaviruses 229E and NL63 Determine Recognition of Their Respective Cellular Receptors journal September 2006

Similar Records

Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2
Journal Article · Thu Oct 29 00:00:00 EDT 2020 · Glycobiology (Online) · OSTI ID:1963813

Glycosylation of SARS-CoV-2: structural and functional insights
Journal Article · Wed Jul 07 00:00:00 EDT 2021 · Analytical and Bioanalytical Chemistry · OSTI ID:1963808

Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2
Journal Article · Mon May 04 00:00:00 EDT 2020 · Glycobiology (Online) · OSTI ID:1964028